Another study applied sodium-butyrate to DKD mice and indicated that it reduced TGF-β, Fn, IL-6, and MCP-1, thus improving DKD by inhibiting renal inflammation [181, 182]. This evidence concerns the gene CCL2 and diabetic kidney disease.